Latest news with #JasonKirby
Globe and Mail
2 days ago
- Business
- Globe and Mail
Morning Update: U.S. and EU make a trade deal
Good morning. The United States struck a trade deal with the European Union, as Canadians look ahead to the Aug. 1 deadline set for our own tariff agreement. More on that below, plus updates from Gaza and the rescue from a B.C. mine collapse. Let's get to it. The latest: The United States struck a framework trade deal with the European Union Sunday that imposes a 15-per-cent U.S. import tariff on most EU goods, including autos, but leaves 50-per-cent levies on steel and aluminum shipments from the 27 member countries of the EU. Plus: The deal also includes a commitment of US$600-billion of EU investments in the United States and significant EU purchases of U.S. energy and military equipment. What's next: In a world of tariff pain, the United States-Mexico-Canada Agreement gives Canada an edge – for now, write Jason Kirby and Mark Rendell in a recent analysis. As reality sets in that the highest U.S. import duties in a century are here to stay, it's reinforced the value of the USMCA, but it could also prove to be a double-edged sword. What else: U.S. and Chinese negotiators are set to resume talks in an effort to extend tariff truce. The latest: The Israeli military on Sunday began a limited pause in fighting in three populated areas of Gaza for 10 hours a day, part of a series of steps that included multiple airdrops as concerns over surging hunger in the territory mount and Israel faces a wave of international criticism over its conduct. As the military had warned, combat operations continued otherwise. What's next: Food experts have spoken for months of the risk of famine in Gaza, where Israel has restricted aid to the population of more than two million because it says, without providing evidence, that Hamas siphons off goods to help bolster its rule. The UN World Food Program said a third of Gaza's population were not eating for days and nearly half a million were enduring famine-like conditions. First person: 'This is now normal in the streets of Gaza. Pale faces, sunken eyes, and thin bodies searching for something to eat. Many don't know if they will find food today or not,' writes Hasan Jaber from the Bureij refugee camp, in the Gaza Strip. The latest: For any weekend warrior, an injury can be a major setback not just to their workouts but to everyday life as well. Healthy living reporter Graham Isador spoke with medical experts and trainers from across the country who share their best practices for preventing and recovering from common tweaks, strains and tears caused by some of the most common workouts. What else: Is testosterone therapy right for you? And why is social media normalizing steroid use? The latest: The Canadian Institutes of Health Research – the country's health research funding agency – announced $44.8-million in new money for dementia and aging-related research initiatives, including the creation of 16 teams that will study everything from Alzheimer's biomarkers to dementia in Indigenous populations. What's next: This week, ending on July 31, researchers from around the globe are descending on downtown Toronto to attend the Alzheimer's Association International Conference, the world's biggest and most influential meeting for dementia research. The latest: Clandestine surveillance, allegations of unsafe chicken and a broken business relationship: Retail report Susan Krashinsky Robertson digs into the odd story behind a Canadian lawsuit against Popeyes Louisiana Kitchen. The case has ignited a war of words between the fast-food chain and its former supplier, ADP Direct Poultry Ltd., with each accusing the other of failures in maintaining product quality. What's next: ADP's allegations, based on months of surveillance, are now at the centre of one of the most bizarre cases of quality control to hit Canada's fast-food industry, leaving a trail of unanswered questions and financial damage. The claims are part of a lawsuit filed by ADP against Popeyes' parent company, Restaurant Brands International Inc., along with a number of Popeyes franchisees. Canada's outdated elevator rules are adding to the housing crisis: Read more from Jonathan English, an infrastructure policy consultant, and Stephen Jacob Smith, the executive director of the Center for Building in North America. For two decades, Sackville, N.B., has welcomed the brightest, most up-and-coming stars in Canadian music to its arts and culture festival. Photographer Colin Medley looks back at its best moments.
Globe and Mail
2 days ago
- Business
- Globe and Mail
The state of Canadian tourism in the ‘elbows up' moment
Travel to the U.S. has plummeted ever since President Donald Trump started talking about annexing Canada and imposing tariffs on us. Politicians on this side of the border are embracing the moment, encouraging people to take trips closer to home. So how is it all working out for Canadian tourism? The Globe's Jason Kirby, who writes for the Report on Business, joins us to talk about what this summer looks like for Canada's travel sector. Questions? Comments? Ideas? Email us at thedecibel@
Globe and Mail
05-06-2025
- Business
- Globe and Mail
Trump doubles down on steel, aluminum tariffs
On Tuesday, U.S. President Donald Trump signed a new executive order that raised tariffs on steel and aluminum from 25 per cent to 50 per cent. One Canadian steel producer said this means that their American business is now 'unviable'. Jason Kirby is a staff reporter for The Globe's Report on Business section. He explains why these higher steel and aluminum tariffs could mean higher prices on nearly everything, and what may have contributed to Trump's escalation. Questions? Comments? Ideas? Email us at thedecibel@
Yahoo
21-04-2025
- Health
- Yahoo
PursueCare to Spotlight Next-Gen Digital Therapeutics at the 56th American Society of Addiction Medicine (ASAM) Conference in Denver April 24-27
Celebrates ASAM Distinguished Fellow Honor for Dr. Jason Kirby DENVER, April 21, 2025--(BUSINESS WIRE)--PursueCare, a leading provider of virtual addiction treatment and specialized pharmacy services, is proud to announce its participation in the 56th Annual American Society of Addiction Medicine (ASAM) Conference in Denver, Colo., April 24-27, 2025. The event gathers top experts, clinicians, and innovators in addiction medicine to advance science, practice, and policy in the field. Honoring a Visionary in Addiction Medicine—Dr. Jason Kirby Named 2025 ASAM Distinguished Fellow PursueCare's Medical Director, Dr. Jason Kirby, DO, MBA, DFASAM, has been named a 2025 Distinguished Fellow of ASAM, one of the society's highest honors. This prestigious designation recognizes Dr. Kirby's enduring commitment to evidence-based, outcomes-driven care and his leadership in improving access to treatment for individuals with substance use disorder (SUD). "I began this journey nearly a decade ago with a mission to provide compassionate, science-backed care for people living with addiction. Being recognized as a Distinguished Fellow by ASAM is a profound honor," said Dr. Kirby. "It's a privilege to stand alongside so many esteemed leaders who are transforming the future of addiction medicine." With dual board certifications in addiction medicine and family medicine, and deep expertise in healthcare policy and population health, Dr. Kirby exemplifies the innovative and empathetic leadership PursueCare brings to the field. Visit PursueCare at Booth #325—Experience RESET® and RESET-O® Conference attendees are invited to Booth #325 to experience PursueCare's cutting-edge, virtual-first addiction treatment platform. The company will spotlight its latest advancements, including: RESET® and RESET-O®—the first and only FDA-authorized digital therapeutics for SUD and opioid use disorder (OUD). Watch the video Transforming Addiction Treatment with RESET®. Tools that offer 24/7 recovery support, blending cognitive behavioral therapy (CBT), contingency management, and real-time progress tracking within PursueCare's secure, proprietary smartphone applications. These groundbreaking therapeutics are seamlessly embedded into PursueCare's care model, extending the reach and impact of virtual addiction care. Elevating the Standards of Recovery "Dr. Kirby's recognition as a Distinguished Fellow is a proud moment for everyone at PursueCare," said Nick Mercadante, Founder and Chief Executive Officer. "His tireless work to expand access and improve outcomes in virtual addiction treatment reflects our mission to reimagine what recovery looks like for people everywhere." With innovation at its core, PursueCare continues to lead the charge in transforming addiction care through accessible, scalable, and data-driven solutions. About PursueCare PursueCare provides personalized virtual addiction treatment for individuals across states (CT, KY, MA, ME, NH, OH, and WV). Our mission is to increase access to chronic care through telehealth. Patients engage with a multi-disciplinary team providing medical care, counseling, psychiatry, and pharmacy. FDA-authorized digital cognitive behavioral therapy, RESET® and RESET-O®, supports recovery 24/7. We accept private insurance, Medicare, and Medicaid. Learn more at and View source version on Contacts Media Andreea Popa Head of Sign in to access your portfolio
Business Wire
21-04-2025
- Health
- Business Wire
PursueCare to Spotlight Next-Gen Digital Therapeutics at the 56 th American Society of Addiction Medicine (ASAM) Conference in Denver April 24-27
DENVER--(BUSINESS WIRE)--PursueCare, a leading provider of virtual addiction treatment and specialized pharmacy services, is proud to announce its participation in the 56th Annual American Society of Addiction Medicine (ASAM) Conference in Denver, Colo., April 24-27, 2025. The event gathers top experts, clinicians, and innovators in addiction medicine to advance science, practice, and policy in the field. With innovation at its core, PursueCare continues to lead the charge in transforming addiction care through accessible, scalable, and data-driven solutions. Share Honoring a Visionary in Addiction Medicine—Dr. Jason Kirby Named 2025 ASAM Distinguished Fellow PursueCare's Medical Director, Dr. Jason Kirby, DO, MBA, DFASAM, has been named a 2025 Distinguished Fellow of ASAM, one of the society's highest honors. This prestigious designation recognizes Dr. Kirby's enduring commitment to evidence-based, outcomes-driven care and his leadership in improving access to treatment for individuals with substance use disorder (SUD). 'I began this journey nearly a decade ago with a mission to provide compassionate, science-backed care for people living with addiction. Being recognized as a Distinguished Fellow by ASAM is a profound honor,' said Dr. Kirby. 'It's a privilege to stand alongside so many esteemed leaders who are transforming the future of addiction medicine.' With dual board certifications in addiction medicine and family medicine, and deep expertise in healthcare policy and population health, Dr. Kirby exemplifies the innovative and empathetic leadership PursueCare brings to the field. Visit PursueCare at Booth #325—Experience RESET® and RESET-O® Conference attendees are invited to Booth #325 to experience PursueCare's cutting-edge, virtual-first addiction treatment platform. The company will spotlight its latest advancements, including: RESET® and RESET-O®—the first and only FDA-authorized digital therapeutics for SUD and opioid use disorder (OUD). Watch the video Transforming Addiction Treatment with RESET®. Tools that offer 24/7 recovery support, blending cognitive behavioral therapy (CBT), contingency management, and real-time progress tracking within PursueCare's secure, proprietary smartphone applications. These groundbreaking therapeutics are seamlessly embedded into PursueCare's care model, extending the reach and impact of virtual addiction care. Elevating the Standards of Recovery 'Dr. Kirby's recognition as a Distinguished Fellow is a proud moment for everyone at PursueCare,' said Nick Mercadante, Founder and Chief Executive Officer. 'His tireless work to expand access and improve outcomes in virtual addiction treatment reflects our mission to reimagine what recovery looks like for people everywhere.' With innovation at its core, PursueCare continues to lead the charge in transforming addiction care through accessible, scalable, and data-driven solutions. About PursueCare PursueCare provides personalized virtual addiction treatment for individuals across states (CT, KY, MA, ME, NH, OH, and WV). Our mission is to increase access to chronic care through telehealth. Patients engage with a multi-disciplinary team providing medical care, counseling, psychiatry, and pharmacy. FDA-authorized digital cognitive behavioral therapy, RESET® and RESET-O®, supports recovery 24/7. We accept private insurance, Medicare, and Medicaid. Learn more at and
